Mutations in the SAMD9 gene are associated with normophosphatemic familial tumoral calcinosis [5, 6] as well as the MIRAGE (myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital phenotypes, and enteropathy) syndrome [7]. This evidence concerns the gene SAMD9 and chronic primary adrenal insufficiency.